A new extra sequence at the amino terminal of a μ heavy chain disease protein (DAG)

1990 ◽  
Vol 27 (8) ◽  
pp. 771-776 ◽  
Author(s):  
C. Mihaesco ◽  
P. Ferrara ◽  
J.C. Guillemot ◽  
N. Congy ◽  
M.C. Gendron ◽  
...  
1984 ◽  
Vol 30 (12) ◽  
pp. 2021-2025 ◽  
Author(s):  
P Blangarin ◽  
P Deviller ◽  
K Kindbeiter ◽  
J J Madjar

Abstract We used two-dimensional polyacrylamide gel electrophoresis and immunoblotting techniques to study serum proteins from a patient with a monoclonal gammopathy. Two-dimensional electrophoresis was optimized for serum proteins with two main goals: (a) to allow the resolution of many serum proteins in both directions, with penetration of the maximum number of proteins in the first dimension; and (b) to obtain the best reproducibility from one experiment to another, within the limits of the current technique. These analyses, combined with immunoblotting, permitted us to characterize a gamma heavy chain disease protein of 34 000-Da molecular mass. Moreover, two-dimensional mapping of the patient's serum proteins allowed demonstration of the microheterogeneity of this monoclonal component.


1976 ◽  
Vol 13 (3) ◽  
pp. 245-249 ◽  
Author(s):  
Yoko Nabeshima ◽  
Tokuji Ikenaka ◽  
Terukatsu Arima

1993 ◽  
Vol 17 (6) ◽  
pp. 527-532 ◽  
Author(s):  
Michel Cogné ◽  
Pierre Aucouturier ◽  
André Brizard ◽  
Brigitte Dreyfus ◽  
Françoise Duarte ◽  
...  

Blood ◽  
1978 ◽  
Vol 51 (1) ◽  
pp. 85-96 ◽  
Author(s):  
JB Adlersberg ◽  
V Grann ◽  
D Zucker-Franklin ◽  
B Frangione ◽  
EC Franklin

Abstract A unique case of gamma3 heavy chain disease with two related serum proteins is reported. One molecule appears to be an IgG3lambda myeloma protein. The second molecule is a dimer of a shortened gamma3 heavy chain that has an unblocked amino terminus and lacks the VH and CH1 domains. Its probable origin as a synthetic product is discussed. The clinical and pathologic features of this patient resemble those of other patients with gamma heavy chain disease more than those of patients with multiple myeloma. It seems likely that the heavy chain disease protein is the result of a mutational event in the malignant clone originally producing the myeloma protein.


1986 ◽  
Vol 83 (8) ◽  
pp. 2689-2693 ◽  
Author(s):  
A. Bakhshi ◽  
P. Guglielmi ◽  
U. Siebenlist ◽  
J. V. Ravetch ◽  
J. P. Jensen ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document